Monitoring and management of MS patients starting natalizumab therapy in Germany - Final results of the prospective TYSTART study

Authors
Category Primary study
JournalJournal of the Neurological Sciences
Year 2013
This article has no abstract
Epistemonikos ID: 7309dffdacb66dad706e4f8be658daf54855bf22
First added on: Feb 05, 2025